Washburn Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
5,435
-43
| -0.8% | -$7.98K | 0.59% | 26 |
|
|
2025
Q1 | $1.15M | Buy |
5,478
+521
| +11% | +$109K | 0.75% | 20 |
|
|
2024
Q4 | $881K | Sell |
4,957
-222
| -4% | -$39.5K | 0.55% | 23 |
|
|
2024
Q3 | $1.02M | Sell |
5,179
-53
| -1% | -$10.5K | 0.73% | 21 |
|
|
2024
Q2 | $897K | Sell |
5,232
-148
| -3% | -$25.4K | 0.64% | 22 |
|
|
2024
Q1 | $980K | Buy |
5,380
+58
| +1% | +$10.6K | 0.72% | 21 |
|
|
2023
Q4 | $825K | Sell |
5,322
-217
| -4% | -$33.6K | 0.62% | 21 |
|
|
2023
Q3 | $826K | Sell |
5,539
-362
| -6% | -$54K | 0.7% | 24 |
|
|
2023
Q2 | $795K | Sell |
5,901
-4,852
| -45% | -$654K | 0.66% | 24 |
|
|
2023
Q1 | $1.71M | Sell |
10,753
-2,617
| -20% | -$417K | 1.48% | 13 |
|
|
2022
Q4 | $2.16M | Buy |
13,370
+508
| +4% | +$82.1K | 1.97% | 11 |
|
|
2022
Q3 | $1.73M | Sell |
12,862
-72
| -0.6% | -$9.66K | 1.65% | 13 |
|
|
2022
Q2 | $1.98M | Sell |
12,934
-512
| -4% | -$78.4K | 1.71% | 13 |
|
|
2022
Q1 | $2.18M | Sell |
13,446
-827
| -6% | -$134K | 1.43% | 13 |
|
|
2021
Q4 | $1.93M | Sell |
14,273
-1,995
| -12% | -$270K | 1.15% | 20 |
|
|
2021
Q3 | $1.76M | Sell |
16,268
-850
| -5% | -$91.7K | 1.15% | 19 |
|
|
2021
Q2 | $1.93M | Sell |
17,118
-926
| -5% | -$104K | 1.29% | 17 |
|
|
2021
Q1 | $1.95M | Buy |
18,044
+632
| +4% | +$68.4K | 1.33% | 19 |
|
|
2020
Q4 | $1.87M | Sell |
17,412
-890
| -5% | -$95.4K | 1.3% | 18 |
|
|
2020
Q3 | $1.6M | Buy |
18,302
+4,116
| +29% | +$361K | 1.27% | 20 |
|
|
2020
Q2 | $1.39M | Buy |
14,186
+4,801
| +51% | +$471K | 1.28% | 20 |
|
|
2020
Q1 | $715K | Buy |
9,385
+2,325
| +33% | +$177K | 0.98% | 21 |
|
|
2019
Q4 | $625K | Buy |
+7,060
| New | +$625K | 0.57% | 22 |
|